Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia

This article reports on results from an overt and mystery client survey in Cambodia

Abstract

The availability of monotherapies and falsified antimalarials is thought to have contributed to the development of multidrug-resistant malaria in Cambodia. This particular study aimed to document the quality of artemisinin-containing antimalarials (ACAs) and compare 2 methods of collecting antimalarials:

  1. open surveyors
  2. mystery clients (MCs)

Citation

Yeung, S.; Lawford, H. S. L.; Tabernero, P,; Nguon, C,; van Wyk, A,; Malik, N,; DeSousa, M,; Rada, O,; Boravann, M,; Dwivedi, P,; Hostetler, D. M.; Swamidoss, I,; Green, M. D,; Fernandez, F. M, and Kaur, H. Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia. American Journal of Tropical Medicine and Hygiene, 2015 June; 92(6 Suppl): 39-50pp

Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia

Updates to this page

Published 20 April 2015